Bitech Technologies Corp. Files S-1/A Amendment
Ticker: BESS-WT · Form: S-1/A · Filed: Jan 22, 2025 · CIK: 1066764
Sentiment: neutral
Topics: amendment, corporate-structure, filing
Related Tickers: BTTC
TL;DR
Bitech Tech (BTTC) filed an S-1/A, formerly Spine Injury Solutions. Check for updates.
AI Summary
Bitech Technologies Corp. filed an S-1/A on January 22, 2025, detailing its business operations. The company, formerly known as Spine Injury Solutions, Inc., is involved in electric services and has undergone several name changes since 2008. Its principal executive offices are located at 895 Dove Street, Suite 300, Newport Beach, CA.
Why It Matters
This filing provides updated information for investors and the public regarding Bitech Technologies Corp.'s corporate structure and business activities.
Risk Assessment
Risk Level: low — This filing is a routine amendment to a registration statement and does not contain new financial performance data or significant business changes.
Key Players & Entities
- Bitech Technologies Corp. (company) — Filer of the S-1/A
- Spine Injury Solutions, Inc. (company) — Former name of Bitech Technologies Corp.
- 895 Dove Street, Suite 300, Newport Beach, CA (location) — Business and mailing address
- January 22, 2025 (date) — Filing date of the S-1/A
FAQ
What is the primary business of Bitech Technologies Corp.?
Bitech Technologies Corp. is classified under Standard Industrial Classification code 4911, which corresponds to Electric Services.
When was Bitech Technologies Corp. formerly known as Spine Injury Solutions, Inc.?
The company's name was changed from Spine Injury Solutions, Inc. on October 7, 2015.
What is the SEC file number for this filing?
The SEC file number for this S-1/A filing is 333-280668.
Where is Bitech Technologies Corp. located?
Bitech Technologies Corp.'s business and mailing address is 895 Dove Street, Suite 300, Newport Beach, CA 92660.
What is the fiscal year end for Bitech Technologies Corp.?
The fiscal year end for Bitech Technologies Corp. is December 31.
Filing Stats: 4,448 words · 18 min read · ~15 pages · Grade level 17.5 · Accepted 2025-01-22 14:59:32
Key Financial Figures
- $0.001 — ering shares of common stock, par value $0.001 per share, at an aggregate assumed offe
- $0.0001 — d to the public in this offering, minus $0.0001. The Pre-Funded Warrants will be immedi
Filing Documents
- forms-1a.htm (S-1/A) — 2427KB
- ex3-11.htm (EX-3.11) — 109KB
- ex10-13.htm (EX-10.13) — 119KB
- ex10-21.htm (EX-10.21) — 166KB
- ex10-22.htm (EX-10.22) — 695KB
- ex10-28.htm (EX-10.28) — 95KB
- ex10-30.htm (EX-10.30) — 35KB
- ex23-1.htm (EX-23.1) — 4KB
- ex107.htm (EX-FILING FEES) — 49KB
- logo_002.jpg (GRAPHIC) — 27KB
- chart_006.jpg (GRAPHIC) — 591KB
- chart_002.jpg (GRAPHIC) — 58KB
- chart_005.jpg (GRAPHIC) — 153KB
- ex10-21_001.jpg (GRAPHIC) — 2KB
- ex10-21_002.jpg (GRAPHIC) — 2KB
- ex10-21_003.jpg (GRAPHIC) — 2KB
- ex23-1_001.jpg (GRAPHIC) — 12KB
- 0001493152-25-003206.txt ( ) — 10295KB
- bttc-20240930.xsd (EX-101.SCH) — 35KB
- bttc-20240930_cal.xml (EX-101.CAL) — 35KB
- bttc-20240930_def.xml (EX-101.DEF) — 202KB
- bttc-20240930_lab.xml (EX-101.LAB) — 286KB
- bttc-20240930_pre.xml (EX-101.PRE) — 251KB
- forms-1a_htm.xml (XML) — 771KB
Underwriting
Underwriting discounts and commissions do not include a non-accountable expense allowance equal to 1.0% of the initial public offering price payable to the underwriters. We refer you to "Underwriting" beginning on page 63 for additional information regarding underwriters' compensation. The offering is being underwritten on a firm commitment basis. We have granted a 45-day option to the representative of the underwriters to purchase up to additional shares of common stock and/or Pre-Funded Warrants solely to cover over-allotments, if any. The underwriters expect to deliver the securities to purchasers on or about , 2025. ThinkEquity The date of this prospectus is , 2025 TABLE OF CONTENTS Page SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS 1 PROSPECTUS SUMMARY 2 THE OFFERING 9
SELECTED FINANCIAL DATA
SELECTED FINANCIAL DATA 11
USE OF PROCEEDS
USE OF PROCEEDS 28 DIVIDEND POLICY 29 CAPITALIZATION 30
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 32
BUSINESS
BUSINESS 39 MANAGEMENT 47 EXECUTIVE AND DIRECTOR COMPENSATION 50 PRINCIPAL STOCKHOLDERS 54 CERTAIN RELATIONSHIPS AND RELATED PARTY 55
DESCRIPTION OF SECURITIES WE ARE OFFERING
DESCRIPTION OF SECURITIES WE ARE OFFERING 56 SHARES ELIGIBLE FOR FUTURE SALE 58 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS 59
UNDERWRITING
UNDERWRITING 63 LEGAL MATTERS 67 EXPERTS 67 WHERE YOU CAN FIND ADDITIONAL INFORMATION 68 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1 OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION II-1 You should rely only on the information contained in this prospectus. We and the underwriter(s) have not authorized anyone to provide you with any information other than that contained in this prospectus, and neither we, nor the underwriter(s) take responsibility for any other information others may give you. We are offering to sell, and seeking offers to buy, common stock and Pre-Funded warrants only in jurisdictions where such offers and sales are permitted. i About this Prospectus Neither nor the Underwriter have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you and which we have filed with the U.S. Securities and Exchange Commission (the "SEC"). We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the common stock and Pre-Funded warrants shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted or where the person making the offer or sale is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained in this prospectus is current only as of the date on the front cover of the prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. Market and Industry Data . This prospectus contains estimates and other statistical data made by independent parties relating to our industry and the markets in